phenethyl isothiocyanate has been researched along with Hyperplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirose, M; Inoue, K; Kato, N; Lee, KY; Shibutani, M; Takagi, H; Uneyama, C | 1 |
| Futakuchi, M; Hirose, M; Kimoto, N; Ogawa, K; Sano, M; Shirai, T; Yamaguchi, T | 1 |
| Cui, L; Hirose, M; Imaida, K; Ogawa, K; Ogiso, T; Shirai, T; Sugiura, S | 1 |
3 other study(ies) available for phenethyl isothiocyanate and Hyperplasia
| Article | Year |
|---|---|
Limited tumor-initiating activity of phenylethyl isothiocyanate by promotion with sodium L-ascorbate in a rat two-stage urinary bladder carcinogenesis model.
Topics: Animals; Ascorbic Acid; Body Weight; Carcinoma; Diet; Hyperplasia; Isothiocyanates; Male; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 2005 |
Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Diet; Diethylnitrosamine; Drug Synergism; Hyperplasia; Isothiocyanates; Liver; Male; Rats; Rats, Inbred F344; Urinary Bladder; Urinary Bladder Neoplasms | 1998 |
Dose-dependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Carcinogens; Diet; Dose-Response Relationship, Drug; Drug Stability; Hyperplasia; Isothiocyanates; Liver Neoplasms; Male; Organ Size; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 2001 |